Literature DB >> 23956034

Predictors of survival in carcinoma ex pleomorphic adenoma.

Michelle M Chen1, Sanziana A Roman, Julie A Sosa, Benjamin L Judson.   

Abstract

BACKGROUND: Carcinoma ex pleomorphic adenoma (Ca ex PA) is a high-grade carcinoma arising from benign pleomorphic adenoma. This is the first population-level analysis of prognosis and prognostic features of parotid Ca ex PA.
METHODS: The Surveillance, Epidemiology, and End Results (SEER) database (1988-2009) was used to identify 278 patients with parotid Ca ex PA.
RESULTS: Extraparenchymal extension of the primary tumor was associated with cervical metastasis (35.7% vs 2.9%; p < .001). Independent predictors of disease-specific survival (DSS) were race (hazard ratio [HR], 7.12; 95% confidence interval [CI], 2.56-19.82), distant metastases (HR, 18.99; 95% CI, 5.06-71.21), and multiple metastatic lymph nodes (HR, 9.48; 95% CI, 4.14-21.71). Patients with multiple cervical lymph node metastases had decreased 5-year DSS compared with patients with ≤1 positive lymph node (42.7% vs 85.9%; p < .001).
CONCLUSION: The presence of 2 or more cervical lymph node metastases identifies patients with Ca ex PA with a poor prognosis.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  carcinoma ex pleomorphic adenoma; metastases; parotid; salivary; survival

Mesh:

Year:  2014        PMID: 23956034     DOI: 10.1002/hed.23453

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  7 in total

1.  The role of adjuvant radiotherapy in management of recurrent pleomorphic adenoma of the parotid gland: a systematic review.

Authors:  Laura Mc Loughlin; Sarah Louise Gillanders; Susan Smith; Orla Young
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-11-13       Impact factor: 2.503

2.  Carcinoma ex-pleomorphic adenoma of the salivary glands has a high risk of progression when the tumor invades more than 2.5 mm beyond the capsule of the residual pleomorphic adenoma.

Authors:  Miguel Rito; Isabel Fonseca
Journal:  Virchows Arch       Date:  2015-12-05       Impact factor: 4.064

3.  Metformin inhibits salivary adenocarcinoma growth through cell cycle arrest and apoptosis.

Authors:  Yuqi Guo; Tao Yu; Jian Yang; Tianqing Zhang; Yang Zhou; Fan He; Zoya Kurago; David Myssiorek; Yingjie Wu; Peng Lee; Xin Li
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

4.  The role of immune surveillance in malignant transformation of benign salivary gland tumors.

Authors:  Maximilian Linxweiler; Jingming Wang; Luc G T Morris
Journal:  Oncotarget       Date:  2021-03-30

5.  Identification of differentially expressed microRNAs as potential biomarkers for carcinoma ex pleomorphic adenoma.

Authors:  Hyojin Kim; Shin Eun; Woo-Jin Jeong; Soon-Hyun Ahn; Yun Jung Bae; Joong Seob Lee; Heejin Kim
Journal:  Sci Rep       Date:  2022-08-04       Impact factor: 4.996

6.  Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period.

Authors:  Michał Żurek; Kamil Jasak; Karolina Jaros; Piotr Daniel; Kazimierz Niemczyk; Anna Rzepakowska
Journal:  Int J Environ Res Public Health       Date:  2022-08-18       Impact factor: 4.614

7.  Carcinoma ex pleomorphic adenoma of major salivary glands: CT and MR imaging findings.

Authors:  Can Wang; Qiang Yu; Siyi Li; Jingjing Sun; Ling Zhu; Pingzhong Wang
Journal:  Dentomaxillofac Radiol       Date:  2021-06-23       Impact factor: 3.525

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.